易明医药：预计2025年度净利润同比增长61.12%至122.08%

Group 1 - The core viewpoint of the article is that Yiming Pharmaceutical (002826) expects a significant increase in net profit for the fiscal year 2025, projecting a range of 74 million to 102 million yuan, which represents a growth of 61.12% to 122.08% compared to the previous year [1]